Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1528486586
Since 2014
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
333 Cottman Ave
Philadelphia, PA, 19111
Phone (215) 728-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
302 services
Medicare patients, 2024
76
Average age 74
Drug cost, 2024
$2.2M
412 prescriptions
Company payments, 2025
$2,054
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph N Bodor was code 99214 (office e&m - established), 145 times for 57 patients. In total Joseph N Bodor billed 302 services in 9 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 145 | 57 | $75.00 | $11K |
| 99215 Office E&M - Established | Facility | 111 | 36 | $107.82 | $12K |
By year: 2022 $31K for 355 services; 2023 $37K for 399 services; 2024 $27K for 302 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph N Bodor prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 60 prescriptions and refills. In total Joseph N Bodor wrote 412 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 60 | 60 | 12 | $984K |
| Ondansetron Hcl Generic | 28 | 28 | 22 | $424 |
| Gilotrif Afatinib Dimaleate | 22 | 22 | Under 11 | $247K |
| Eliquis Apixaban | 21 | 29 | Under 11 | $17K |
| Prednisone Generic | 20 | 23 | 15 | $143 |
| Buprenorphine Generic | 17 | 17 | Under 11 | $2,980 |
| Alecensa Alectinib Hcl | 15 | 15 | Under 11 | $253K |
| Oxycodone Hcl Generic | 15 | 15 | 11 | $102 |
| Olanzapine Generic | 15 | 15 | Under 11 | $76.5 |
| Alunbrig Brigatinib | 15 | 15 | Under 11 | $305K |
| Dexamethasone Generic | 15 | 15 | Under 11 | $319 |
| Pantoprazole Sodium Generic | 12 | 22 | Under 11 | $93.38 |
| Hydrocortisone Generic | 12 | 12 | Under 11 | $197 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 11 | 12 | Under 11 | $26.93 |
Brand drugs: 176 claims; generic drugs: 236 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph N Bodor $2,054 ($2,054 in general payments such as food, travel and fees) from 6 companies. The largest payer was AstraZeneca UK Limited with $1,920.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.